TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy
Tanjing Song1, Suli Lv2, Xianyun Ma2
1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Cell Architecture Research Institute, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Abstract:
Autophagy plays a pivotal role in physiology and pathophysiology, including cancer. Mechanisms of autophagy dysregulation in cancer remain elusive. Loss of function of TRIM28, a multifunction protein, is seen in familial kidney malignancy, but the mechanism by which TRIM28 contributes to the etiology of kidney malignancy is unclear. In this study, we show TRIM28 retards kidney cancer cell proliferation through inhibiting autophagy. Mechanistically, we find TRIM28 promotes ubiquitination and proteasome-mediated degradation of transcription factor TFE3, which is critical for autophagic gene expression. Genetic activation of TFE3 due to gene fusion is known to cause human kidney malignancy, but whether and how transcription activation by TFE3 involves chromatin changes is unclear. Here, we find another mode of TFE3 activation in human renal carcinoma. We find that TFE3 is constitutively localized to the cell nucleus in human and mouse kidney cancer, where it increases autophagic gene expression and promotes cell autophagy as well as proliferation. We further uncover that TFE3 interacts with and recruits histone H3K27 demethylase KDM6A for autophagic gene upregulation. We reveal that KDM6A contributes to expression of TFE3 target genes through increasing H3K4me3 rather than demethylating H3K27. Collectively, in this study, we identify a functional TRIM28-TFE3-KDM6A signal axis, which plays a critical role in kidney cancer cell autophagy and proliferation.
Insights
The TRIM28-TFE3-KDM6A pathway regulates kidney cancer cell growth by controlling autophagy. TRIM28 inhibits TFE3, a key factor in autophagic gene expression, thus slowing cancer proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Autophagy is crucial in cancer, but its dysregulation mechanisms are unclear.
- TRIM28 loss is linked to kidney cancer, yet its role is not fully understood.
- TFE3 gene fusions cause kidney cancer, but TFE3's broader role in chromatin regulation needs clarification.
Purpose of the Study:
- To elucidate the mechanism by which TRIM28 influences kidney cancer.
- To investigate the role of TFE3 and KDM6A in kidney cancer cell proliferation and autophagy.
- To identify key signaling pathways regulating kidney cancer progression.
Main Methods:
- Investigated TRIM28's effect on autophagy and kidney cancer cell proliferation.
- Analyzed TRIM28-mediated ubiquitination and degradation of TFE3.
- Examined TFE3 nuclear localization and its interaction with KDM6A in kidney cancer cells.
- Assessed the impact of KDM6A on histone modifications and gene expression.
Main Results:
- TRIM28 inhibits kidney cancer cell proliferation by suppressing autophagy.
- TRIM28 promotes TFE3 degradation, a transcription factor essential for autophagic gene expression.
- TFE3 is constitutively nuclear in kidney cancer, upregulating autophagic genes and promoting proliferation.
- TFE3 recruits KDM6A to enhance autophagic gene expression via H3K4me3 modification, not H3K27 demethylation.
Conclusions:
- Identified a TRIM28-TFE3-KDM6A signaling axis critical for kidney cancer.
- TRIM28 acts as a tumor suppressor by inhibiting autophagy through TFE3 degradation.
- TFE3 and KDM6A promote kidney cancer cell autophagy and proliferation via epigenetic modifications.
More Related Videos
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Replicative Cell Senescence
